Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapitaLynx is a specialized strategic consultancy that provides market access, pricing, and reimbursement solutions to the global life sciences sector. The firm supports pharmaceutical and biotechnology companies in developing robust value propositions and navigating the complexities of health technology assessments (HTA). Their expertise spans the product lifecycle, from early-stage commercial potential evaluation to post-launch pricing maintenance. By leveraging deep industry insights, CapitaLynx helps clients secure optimal patient access for innovative medical treatments. The company is headquartered in London and operates on a global scale, bridging the gap between clinical development and commercial success.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapitaLynx.